HOME >> BIOLOGY >> NEWS
Findings suggest need for new view of p53 cancer protein's interaction with DNA

PHILADELPHIA Perhaps the most commonly mutated of all cancer-linked genes is the gene for a tumor suppressor called p53. Scientists estimate that at least half of human cancers involve mutant p53. In the course of performing its regular duties, the normal p53 protein binds to DNA, and a number of cancer-linked p53 mutations affect the DNA-binding region of the p53 protein.

But precisely how does the p53 protein bind to DNA? Since DNA binding is crucial to the protein's usual function, the answer to this question is key to drug development efforts aimed at countering the effects of p53 mutations. Scientists thought that they had a good window on the p53 protein's interactions with DNA from structural studies that showed a single copy of the protein bound to DNA in a particular conformation.

Now a team of researchers from The Wistar Institute, the Memorial Sloan-Kettering Cancer Center, and the Howard Hughes Medical Institute report on new structural studies that will likely lead scientists to revise their views of how the p53 protein binds to DNA. The findings appear in today's issue of the journal Structure.

"Mutant forms of p53 in human cancer are often defective in their binding to DNA, and a number of groups are trying to develop drugs that might treat cancer by restoring the DNA-binding activity of these mutants," says Thanos D. Halazonetis, D.D.S., Ph.D., associate professor in the molecular and cellular oncogenesis program at Wistar and senior author on the Structure study. "A full understanding of precisely how p53 binds to DNA is essential for this work, however. Our studies suggest that we may need to adjust the existing model of how p53 binds to DNA."

Taking advantage of the fact that evolution commonly conserves vital proteins from species to species, Halazonetis and his colleagues solved the structure of the binding region of a protein called Cep-1 from C. elegans, a roundworm, and compared it to the binding region of hum
'"/>

Contact: Franklin Hoke
hoke@wistar.upenn.edu
215-898-3716
The Wistar Institute
14-Jul-2004


Page: 1 2

Related biology news :

1. Findings redefine mechanism of action of RNA helicase enzymes
2. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
3. Findings could aid efforts to harness nature for making drugs
4. Findings offer clue to how molecule can both stimulate, suppress cell growth
5. Findings offer further understanding about growth and development in young male gymnasts
6. Findings in frog oocytes may help study of chromosome physiology
7. Findings aid understanding of neurodegenerative diseases
8. Findings show exceptional longevity runs in families
9. Findings give insight into how colon cells transform into precancerous polyps
10. Findings conclude sustained caffeine intake negates the benefits of creatine supplements
11. Findings link disease specific anitbodies to activation of T cells for the first time

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/27/2019)... ... October 26, 2019 , ... Since 2010, The HOTH has served over 200,000 ... success of their clients, they’ve earned a place on the highly-competitive and desirable Inc. ... many additional awards and accolades along the way. , Now, The HOTH ...
(Date:10/26/2019)... (PRWEB) , ... October 24, 2019 , ... World Cord ... for parents, doctors, nurses, and midwives to learn about the current and future uses ... , Cord blood is now being used to treat and cure over 80 different ...
(Date:10/26/2019)... PLATA, Md. (PRWEB) , ... October 25, 2019 ... ... an in-office training on myofunctional therapy in La Plata, MD. Orofacial myofunctional disorders ... how a patient eats, sleeps and speaks. This can include anything from difficulty ...
Breaking Biology News(10 mins):
(Date:11/2/2019)... YORK (PRWEB) , ... October 31, 2019 , ... ... been released by pharma artificial intelligence pioneer tellic. drug360 brings tellic’s expertise ... This new tool allows researchers to quickly uncover relationships between genes, diseases, variants, ...
(Date:10/29/2019)... ... 29, 2019 , ... Modality Solutions, a biopharmaceutical ... chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, November 11-12, 2019, ... Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge technology providers, and ...
(Date:10/22/2019)... SOMERSET, N.J. (PRWEB) , ... October 22, 2019 , ... ... Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel ... Logistics Conference (HPCLC), to be held at the Gwen Hotel, Chicago, on Oct. 28-30, ...
(Date:10/17/2019)... HAVEN, Conn. (PRWEB) , ... October 16, 2019 ... ... company that provides personalized, easy-to-understand, web-based genetic counseling information, has published a new ... a five year period and provides guidance as to how patients and medical ...
Breaking Biology Technology:
Cached News: